| Product Code: ETC6665344 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Psoriasis Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Psoriasis Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Psoriasis Market - Industry Life Cycle |
3.4 Canada Psoriasis Market - Porter's Five Forces |
3.5 Canada Psoriasis Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Canada Psoriasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Canada Psoriasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Canada Psoriasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Canada Psoriasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Psoriasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis in Canada |
4.2.2 Growing awareness about psoriasis treatment options |
4.2.3 Technological advancements in psoriasis therapies |
4.3 Market Restraints |
4.3.1 High cost associated with biologic treatments for psoriasis |
4.3.2 Stringent regulations and approval process for new psoriasis drugs |
4.3.3 Limited access to specialized dermatologists in certain regions of Canada |
5 Canada Psoriasis Market Trends |
6 Canada Psoriasis Market, By Types |
6.1 Canada Psoriasis Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Canada Psoriasis Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Canada Psoriasis Market Revenues & Volume, By Nail Psoriasis, 2021- 2031F |
6.1.4 Canada Psoriasis Market Revenues & Volume, By Guttate Psoriasis, 2021- 2031F |
6.1.5 Canada Psoriasis Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2 Canada Psoriasis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Canada Psoriasis Market Revenues & Volume, By Tumour necrosis factor inhibitors, 2021- 2031F |
6.2.3 Canada Psoriasis Market Revenues & Volume, By Vitamin D analogues, 2021- 2031F |
6.2.4 Canada Psoriasis Market Revenues & Volume, By Interleukin-inhibitors, 2021- 2031F |
6.3 Canada Psoriasis Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Canada Psoriasis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.3.3 Canada Psoriasis Market Revenues & Volume, By Skin Biopsy, 2021- 2031F |
6.4 Canada Psoriasis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Canada Psoriasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Canada Psoriasis Market Revenues & Volume, By Topical, 2021- 2031F |
6.5 Canada Psoriasis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Canada Psoriasis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Canada Psoriasis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Canada Psoriasis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Canada Psoriasis Market Import-Export Trade Statistics |
7.1 Canada Psoriasis Market Export to Major Countries |
7.2 Canada Psoriasis Market Imports from Major Countries |
8 Canada Psoriasis Market Key Performance Indicators |
8.1 Patient engagement and adherence to prescribed treatment plans |
8.2 Rate of adoption of new psoriasis therapies |
8.3 Patient satisfaction with available treatment options |
9 Canada Psoriasis Market - Opportunity Assessment |
9.1 Canada Psoriasis Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Canada Psoriasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Canada Psoriasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Canada Psoriasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Canada Psoriasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Psoriasis Market - Competitive Landscape |
10.1 Canada Psoriasis Market Revenue Share, By Companies, 2024 |
10.2 Canada Psoriasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here